T Lange, T Bumm, S Otto, HK Al-Ali, I Kovacs, D Krug, T Kohler, R Krahl, D Niederwieser, MW Deininger. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. haematol [Internet]. 2004Jan.1 [cited 2024Nov.22];89(1):49-7. Available from: https://haematologica.org/article/view/2958